Hikma Pharmaceuticals PLC (HIK)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
2,148.00p
Buy
2,152.00p
4.00p (+0.19%)
Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.
Prices updated at 02 Jun 2025, 18:01 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Said Darwazah
CEO
Mr. Riad Mishlawi
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
9,500
Head office
1 New Burlington Place
London
United Kingdom
W1S 2HR
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Mr. Mohammed Ali Khaldoun S Al-Husry Non-Executive Director | - | - | - | 0.12m | - |
Mr. Douglas Michael Hurt Non-Executive Director | - | - | - | 0.15m | - |
Ms. Nina Henderson Non-Executive Director | - | - | - | 0.18m | - |
Mr. John Julius Castellani Non-Executive Director | - | - | - | 0.17m | - |
Ms. Cynthia L. Flowers Non-Executive Director | - | - | - | 0.13m | - |
Dr. Deneen Vojta, M.D. Non-Executive Director | - | - | - | - | - |
Mr. Mazen Samih Taleb Darwazah Executive Director, Vice Chairman | - | - | - | - | - |
Mr. Riad Mishlawi Executive Director, Chief Executive Officer | - | - | - | - | - |
Mr. Said Darwazah Executive Director, Chairman | - | - | - | - | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 4,722,645 | 0.27998 | 37640 | - | 31 May 2025 | 2.14 |
| Mawer Investment Management Ltd | 3,829,539 | 10.12096 | -146858 | - | 31 May 2025 | 1.74 |
| Mawer Global Small Cap Fund | 3,558,892 | 5.06582 | - | - | 31 May 2025 | 1.61 |
| BlackRock Fund Advisors | 3,054,092 | 0.64472 | -154047 | - | 31 May 2025 | 1.39 |
| Royal London Asset Management Ltd | 2,870,118 | 4.97212 | -210965 | - | 31 May 2025 | 1.30 |
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| 06 May 2025 | D | Mr. Riad Mishlawi | 2023.00 | 29,414 | 80,499 | 0.04 | Dividend Reinvestment Plan(DRIP) |
| 28 Feb 2025 | Transfer in | Mr. Mazen Samih Taleb Darwazah | - | - | 8,159,613 | 3.70 | - |
| 28 Feb 2025 | Transfer in | Mr. Said Darwazah | - | - | 14,271,811 | 6.47 | - |
| 28 Feb 2025 | Transfer in | Mr. Riad Mishlawi | - | - | 59,155 | 0.03 | - |
| 28 Feb 2025 | Exercise of Option | Mr. Riad Mishlawi | - | - | 79,045 | 0.04 | - |
| 23 Sep 2024 | D | Mr. Riad Mishlawi | 1903.00 | 9,686 | 40,464 | 0.02 | Dividend Reinvestment Plan(DRIP) |
Please note that past performance is not a reliable indicator of future returns.
